myalgic encephalomyelitis glutathione low levels in chronic fatigue syndrome encephalomyelitis/chronic (ME/CFS): diagnosis and management Great to see ME/CFS drug

sLASER is the recommended sequence for high and ultra-high field MRS (z et al., 2021)

The prices are great too

Bunion pain often feels like a persistent, aching soreness at the base of the big toe, where the bunion forms

however, no G6PD deficiency has been reported in this unique situation because all affected patients are heterozygotes and presumably in the blood there is overwhelming selection in favor of the cells in which the active X chromosome has the normal Gd allele

Disclosures: Mazen Noureddin: ltimmune, BI, Cytodyn, 89BIO, GSK, Madrigal, Merck, Novo Nor: Terns,Takeda, Zydus., Allergan, Akero, BI, BMS, Gilead, Galectin, Zydus GSK: Terns, Corcept, Takeda, Madrigal, Novartis, Novo Nordisk, Rivus Pharma, Cytodyn, and ChronWell: Stock privately held company, Corinna Schoelch: Nothing to Disclose, Elisabetta Bugianesi: Nothing to Disclose, Naim Alkhouri: Madrigal: Grant/Research Support, Madrigal: Speaking and Teaching, Novo Nordisk: Consulting, Novo Nordisk: Grant/Research Support, Gilead: Grant/Research Support, Corcept: Grant/Research Support, Boehringer Ingelheim: Grant/Research Support, Echosens: Speaking and Teaching, Perspectum: Consultant, Cima: Consultant, Fibronostics: Consultant, 89Bio: Grant/Research Support, Inventiva: Grant/Research Support, Merck: Grant/Research Support, Pfizer: Grant/Research Support, Ipsen: Speaking and Teaching, Intercept: Speaking and Teaching, Madrigal: Consulting, Research Funding, Novo Nordisk: Consulting, Research Funding, Inventiva: Research Funding, Boehringer Ingelheim: Consulting, Research Funding, Corcept: Research Funding, Ipsen: Consulting, Research Funding, Gliead: Consulting, Research Funding, Speaking, Perspectum: Consulting, Research Funding, Cima: Advisor, 89Bio: Consulting, Research Funding, Akero: Grant/Research Support, Mandy Fraessdorf: Nothing to Disclose, Jrn Schattenberg: Apollo Endoscopy, Boehringer Ingelheim, Gilead Sciences: Consultant, Intercept Pharmaceuticals: Consultant, Ipsen, Inventiva Pharma, Madrigal Pharmaceuticals: Consultant, MSD, Northsea Therapeutics, Novartis, Novo Nordisk: Consultant, Pfizer, Roche, Sanofi, and Siemens Healthineers: Consultant, Boehringer Ingelheim, Siemens Healthcare GmbH: Grant/Research Support, AGED diagnostics, and Hepta Bio: Stock privately held company, Alentis, Alexion, Altimmune, Astra Zeneca, 89Bio,Bionorica,: Consultant, Boehringer Ingelheim, Gilead Sciences, GSK, Ipsen, Inventiva: Consultant, Madrigal Pharmaceuticals, Lilly, MSD, Northsea Therapeutics,: Consultant, Novo Nordisk, Pfizer, Roche, Sanofi, and Siemens Healthineer: Consultant, AbbVie, Academic Medical Education (AME),: Speaking and Teaching, Boehringer Ingelheim, Echosens: Speaking and Teaching, Forum fr Medizinische Fortbildung (FOMF), Gilead Sciences: Speaking and Teaching, MedicalTribune, MedPublico GmbH, MedScape,: Speaking and Teaching, Novo Nordisk, Madrigal Pharmaceuticals,: Speaking and Teaching, AGED diagnostics, and Hepta Bio.: Stock privately held company, Philip Newsome: Novo Nordisk: Consultant, B Ingelheim: Consultant, Madrigal: Consultant, 89 Bio: Consultant, Sagimet: Consultant, Echosens: Speaking and Teaching, Eli Lilly: Speaking and Teaching, Zydus Therapeutics: Consultant, Abbott: Speaking and Teaching, Quentin Anstee: AstraZeneca, Boehringer Ingelheim, Intercept.: Grant/Research Support, Alimentiv, Akero, AstraZeneca, Axcella, 89Bio: Consultant, Boehringer Ingelheim, Bristol Myers Squibb, Corcept: Consultant, Enyo Pharma, Galmed, Genfit, Genentech, Gilead, GlaxoSmithKl: Consultant, Hanmi, HistoIndex, Intercept, Inventiva, Ionis, IQVIA, Janss: Consultant, Madrigal, Medpace, Merck, Metadeq, NGMBio, North Sea T: Consultant, Novartis, Novo Nordisk, PathAI, Pfizer, Pharmanest: Consultant, Poxel, Prosciento, Resolution Therapeutics, Roche,: Consultant, Ridgeline Therapeutics, RTI, Shionogi, Terns: Consultant, Fishawack, Integritas Communications, Kenes,: Speaking and Teaching, Novo Nordisk, Madrigal, Medscape, Springer Healthcare: Speaking and Teaching, Elsevier Ltd: Royalties or patent beneficiary, Guy Neff: Nothing to Disclose, Harvey Coxson: Boehringer Ingelheim Pharma GmbH & Co